These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 14587216)
41. A collaborative study to establish a Korean Standard for factor VIII:C concentrate. Kang HN; Kim SN; Lee SH; Hong SH Thromb Res; 2004; 113(3-4):261-7. PubMed ID: 15140591 [TBL] [Abstract][Full Text] [Related]
42. Collaborative study on assays of activated FIX (FIXa). On behalf of the factor VIII and factor IX subcommittee of the ISTH. International Society on Thrombosis and Haemostasis. Gray E; Walker D; Heath A; Barrowcliffe TW Thromb Haemost; 1996 Dec; 76(6):1114-7. PubMed ID: 8972040 [TBL] [Abstract][Full Text] [Related]
43. Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta. Meager A; Das RG J Immunol Methods; 2005 Nov; 306(1-2):1-15. PubMed ID: 16226271 [TBL] [Abstract][Full Text] [Related]
44. Multi-center calibration of the third BCR reference material for thromboplastin, rabbit, plain, coded CRM 149S. Long-term stability of previous BCR reference materials. van den Besselaar AM Thromb Haemost; 1995 Dec; 74(6):1465-7. PubMed ID: 8772221 [TBL] [Abstract][Full Text] [Related]
45. An International Standard for specifying the minimum potency of anti-D blood-grouping reagents: evaluation of a candidate preparation in an international collaborative study. Thorpe SJ; Fox B; Heath AB; Scott M; de Haas M; Kochman S; Padilla A Vox Sang; 2006 Feb; 90(2):131-9. PubMed ID: 16430672 [TBL] [Abstract][Full Text] [Related]
46. A collaborative study to establish the 2nd International Standard for Fibrinogen, Plasma. Whitton CM; Sands D; Hubbard AR; Gaffney PJ Thromb Haemost; 2000 Aug; 84(2):258-62. PubMed ID: 10959698 [TBL] [Abstract][Full Text] [Related]
47. International collaborative study to evaluate candidate reference reagents to standardize haemagglutination testing for anti-A and anti-B in normal intravenous immunoglobulin products. Thorpe SJ; Fox B; Sharp G; Heath AB; Behr-Gross ME; Terao E; Virata-Theimer ML; Yu MW Vox Sang; 2009 Aug; 97(2):160-8. PubMed ID: 19402856 [TBL] [Abstract][Full Text] [Related]
48. International collaborative study for the calibration of a proposed reference preparation for thromboplastin, human recombinant, plain. On behalf of the Subcommittee on Control of Anticoagulation. Tripodi A; Chantarangkul V; Negri B; Clerici M; Mannucci PM Thromb Haemost; 1998 Feb; 79(2):439-43. PubMed ID: 9493604 [TBL] [Abstract][Full Text] [Related]
49. Collaborative study to evaluate a working reagent for West Nile virus RNA detection by nucleic acid testing. Saldanha J; Shead S; Heath A; Drebot M; Transfusion; 2005 Jan; 45(1):97-102. PubMed ID: 15647024 [TBL] [Abstract][Full Text] [Related]
50. Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays. Konnick EQ; Williams SM; Ashwood ER; Hillyard DR J Clin Microbiol; 2005 May; 43(5):2133-40. PubMed ID: 15872232 [TBL] [Abstract][Full Text] [Related]
51. [Analysis of the results of the SEIMC External Quality Control Program for HIV-1 and HCV viral loads, 2007]. ; Orta Mira N; Guna Serrano Mdel R; Latorre Martínez JC; Ovies MR; Pérez JL; Gimeno Cardona C Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 13():8-13. PubMed ID: 19100161 [TBL] [Abstract][Full Text] [Related]
53. Diagnostic algorithm for chronic hepatitis C virus infection: role of the new HCV-core antigen assay. Tillmann HL; Wiegand J; Glomb I; Jelineck A; Picchio G; Wedemeyer H; Manns MP Z Gastroenterol; 2005 Jan; 43(1):11-6. PubMed ID: 15650966 [TBL] [Abstract][Full Text] [Related]
54. International standards for minimum potency of anti-A and anti-B blood grouping reagents: evaluation of candidate preparations in an international collaborative study. Thorpe SJ; Fox B; Heath AB; Scott M; de Haas M; Kochman S; Padilla A Vox Sang; 2006 Nov; 91(4):336-44. PubMed ID: 17105610 [TBL] [Abstract][Full Text] [Related]
55. Clinical performance of the new rRoche COBAS TaqMan HCV Test and High Pure System for extraction, detection and quantitation of HCV RNA in plasma and serum. Gelderblom HC; Menting S; Beld MG Antivir Ther; 2006; 11(1):95-103. PubMed ID: 16518965 [TBL] [Abstract][Full Text] [Related]
56. Verification of an assay for quantification of hepatitis C virus RNA by use of an analyte-specific reagent and two different extraction methods. Forman MS; Valsamakis A J Clin Microbiol; 2004 Aug; 42(8):3581-8. PubMed ID: 15297501 [TBL] [Abstract][Full Text] [Related]
57. A collaborative study to establish a Korea national biological standard for antithrombin concentrate. Kang HN; Han Lee S; Nam Kim S; Man Hong C; Ho Lee S; Hwa Hong S Thromb Res; 2006; 117(5):591-6. PubMed ID: 15992867 [TBL] [Abstract][Full Text] [Related]
58. Antibodies to a novel antigen in acute hepatitis C virus infections. Tobler LH; Stramer SL; Chien DY; Lin S; Arcangel P; Phelps BH; Cooper SL; Busch MP Vox Sang; 2007 Jan; 92(1):1-7. PubMed ID: 17181584 [TBL] [Abstract][Full Text] [Related]
59. Accuracy of hepatitis C virus core antigen testing in pools among seroconverters. Beer N; Shinar E; Novack L; Safi J; Soliman H; Yaari A; Goldman-Levi R; Yahalom V; Bolotin A; Sarov B Transfusion; 2006 Oct; 46(10):1822-8. PubMed ID: 17002640 [TBL] [Abstract][Full Text] [Related]
60. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals. Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]